Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop
tumor cells from dividing so they stop growing or die. Some tumors become resistant to
chemotherapy drugs. Giving interferon alfa and isotretinoin together with paclitaxel may
reduce resistance to the drug and allow the tumor cells to be killed.
PURPOSE: This phase II trial is studying how well giving interferon alfa and isotretinoin
together with paclitaxel works in treating patients with recurrent small cell lung cancer.